Research and Drug Development
A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases
Published by Wiley
Research and Drug DevelopmentClinical Trial Designpeer reviewed journal article on a neutral comparison of statistical methods for longitudinal ordinal outcomes
View this resource Bookmark this resource
How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?
Published by Oxford Academic
Research and Drug DevelopmentClinical Trial Designpeer reviewed journal article on a neutral comparison of statistical methods for longitudinal count data and binary data
View this resource Bookmark this resource
Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials
Published by Springer
Clinical Trial DesignResearch and Drug DevelopmentGuidelinespeer reviewed journal article on statistical recommendations for longitudinal cross-over studies in rare disease research
View this resource Bookmark this resource
Learning video project overview
Published by EBStatMax team
Research and Drug DevelopmentClinical Trial Design
Learning video statistical recommendations
Published by EBStatMax team
GuidelinesResearch and Drug DevelopmentClinical Trial Design
Learning video educational materials
Published by EBStatMax team
Clinical Trial DesignResearch and Drug Development
Learning video Rare Disease Analyser
Published by EBStatMax team
Patient DataClinical Trial DesignResearch and Drug Development
Rare Disease Analyser GitHub repository
Published by Konstantin Emil Thiel (EBStatMax)
Patient DataClinical Trial DesignResearch and Drug DevelopmentSource code of the Rare Disease Analyser, the webapp that implements statistical methods for rare diseases
View this resource Bookmark this resource
User Manual for the Rare Disease Analyser
Published by EBStatMax team
Research and Drug DevelopmentClinical Trial DesignPatient Data